Literature DB >> 27821899

Immunocompetence in adults: more than HIV negative.

Andres Felipe Zea-Vera1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27821899      PMCID: PMC5091278     

Source DB:  PubMed          Journal:  Colomb Med (Cali)        ISSN: 0120-8322


× No keyword cloud information.
Dear editor I read a case report about Tuberculosis and fungal co-infection in a previously healthy patient published in Colomb Med (Cali) by Fontalvo et al. 1 ( https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975131/), and I would like to address some related comments. Frequently clinicians report adult cases of patients with opportunistic infections as disseminated tuberculosis and/or fungal infections in patients consider as immunocompetent based mainly in the absence of human immunodeficiency virus infection (HIV negative). Immunocompetence is more complex than absence of HIV infection and involves a normal capacity to develop an immune response following the exposure to an antigen or broadly a normal immune response, but usually immunocompetent is define as the opposite of immunodeficiency. In the report authors said "Our aim is to report the case of an immunocompetent patient diagnosed with Mycobacterium tuberculosis and Candida albicans co-infections" but my deliberation is Do we make in the clinical practice all the efforts to consider a patient as immunocompetent? Mycobacterial, fungal and other opportunistic infections force the clinician to rule out a large list of conditions associated with secondary immunodeficiency as infectious agents (HIV, Herpesvirus, HTLV), drugs (steroids, immunosuppressants, biologics, chemotherapy) , metabolic diseases (diabetes, renal failure, cirrhosis), malignancies (leukemia, lymphomas and solid tumors) and environmental conditions (radiation, heavy metals) 2 but even adult patients can have late onset primary genetic immunodeficiency disorders as chronic granulomatous disease, X-linked agammaglobulinemia, interleukin-12 receptor deficiency or interferon-gamma (IFN-γ) and interleukin-23/interleukin-17 pathway defects 3 explaining their pattern of infection or the presence of opportunistic microorganism. When a patient with opportunistic infections is assessed cellular immune response evaluation is mandatory, not only CD4+ and CD8+ T lymphocytes absolute quantification (not evaluated in this case report) but also qualitative T cell responses (v.g lymphoproliferation, cytokine production) as well as B cell and natural killer (NK) cells evaluation. Opportunistic infections in adult patients can also be a presentation of autoantibodies that inhibit cytokines including (but not only) anti interferon-gamma (anti IFN-γ) self-antibodies in previously healthy adults presenting with severe Mycobacterial infections 4 or antibodies to interleukin-17 (IL-17) and IL-22 that are associated with chronic candidiasis 5 this group of autoantibodies are now recognized as phenocopies or acquire immune disorders resembling primary genetic immunodeficiency diseases 6. From my point of view the term immunocompetent should be use more carefully. Interestingly the patient presented had mild macrocytic anemia (hemoglobin 10.7 g/dL and mean corpuscular volume 103 μm3). This feature is found frequently in patients with anti-cytokines autoantibodies and is related with self-antibodies to gastric parietal cell and to intrinsic factor producing pernicious anemia 7. Patients with adult onset immunodeficiency due to anti IFN-γ autoantibodies could be more susceptible to autoimmune disorders, requiring a higher suspicious index. The intent of this letter is to generate a wake-up call for better evaluation of patients with recurrent or opportunistic infections.
  7 in total

Review 1.  Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves.

Authors:  Katharine S Nelson; David B Lewis
Journal:  Curr Opin Infect Dis       Date:  2010-08       Impact factor: 4.915

Review 2.  Anticytokine autoantibodies in infectious diseases: pathogenesis and mechanisms.

Authors:  Sarah K Browne; Steven M Holland
Journal:  Lancet Infect Dis       Date:  2010-12       Impact factor: 25.071

3.  Adult-onset immunodeficiency in Thailand and Taiwan.

Authors:  Sarah K Browne; Peter D Burbelo; Ploenchan Chetchotisakd; Yupin Suputtamongkol; Sasisopin Kiertiburanakul; Pamela A Shaw; Jennifer L Kirk; Kamonwan Jutivorakool; Rifat Zaman; Li Ding; Amy P Hsu; Smita Y Patel; Kenneth N Olivier; Viraphong Lulitanond; Piroon Mootsikapun; Siriluck Anunnatsiri; Nasikarn Angkasekwinai; Boonmee Sathapatayavongs; Po-Ren Hsueh; Chi-Chang Shieh; Margaret R Brown; Wanna Thongnoppakhun; Reginald Claypool; Elizabeth P Sampaio; Charin Thepthai; Duangdao Waywa; Camilla Dacombe; Yona Reizes; Adrian M Zelazny; Paul Saleeb; Lindsey B Rosen; Allen Mo; Michael Iadarola; Steven M Holland
Journal:  N Engl J Med       Date:  2012-08-23       Impact factor: 91.245

4.  Tuberculosis and pulmonary candidiasis co-infection present in a previously healthy patient.

Authors:  Dilia Mildret Fontalvo; Gustavo Jiménez Borré; Doris Gómez Camargo; Neylor Chalavé Jiménez; Javier Bellido Rodríguez; Bernarda Cuadrado Cano; Shirley Navarro Gómez
Journal:  Colomb Med (Cali)       Date:  2016-06-30

Review 5.  Secondary immunodeficiencies, including HIV infection.

Authors:  Javier Chinen; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2009-12-29       Impact factor: 10.793

Review 6.  Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015.

Authors:  Capucine Picard; Waleed Al-Herz; Aziz Bousfiha; Jean-Laurent Casanova; Talal Chatila; Mary Ellen Conley; Charlotte Cunningham-Rundles; Amos Etzioni; Steven M Holland; Christoph Klein; Shigeaki Nonoyama; Hans D Ochs; Eric Oksenhendler; Jennifer M Puck; Kathleen E Sullivan; Mimi L K Tang; Jose Luis Franco; H Bobby Gaspar
Journal:  J Clin Immunol       Date:  2015-10-19       Impact factor: 8.317

7.  Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.

Authors:  Adrien Katalin Sarkadi; Szilvia Taskó; Gabriella Csorba; Beáta Tóth; Melinda Erdős; László Maródi
Journal:  J Clin Immunol       Date:  2014-02-04       Impact factor: 8.542

  7 in total
  1 in total

1.  Characteristics of nocardiosis patients with different immune status from a Chinese tertiary general hospital during 8-year period: A STROBE-compliment observational study.

Authors:  Lei Huang; Liying Sun; Yan Yan
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.